Ireland
--:--IST
Recruiting Observational

A Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers

NCT07337109 · tracked via the Priya Life Science USA tracker
Sponsor
Phase
Observational
Started
2025-12-16
Last updated
2026-04-28

Condition(s) studied

Dentin Hypersensitivity

Study summary

The primary purpose of this study is to characterize changes in Oral-Health-Related Quality of Life (OHrQoL), as measured by the Dentin Hypersensitivity Experience Questionnaire (DHEQ) over a 12-month period.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Participant who has provided consent indicating they have been informed of all pertinent aspects of the study. * All genders who, at the time of screening, are aged more than or equal to (\>=)18 years. * Anyone who has begun to experience dentin hypersensitivity (self-reported) within the past three months. * Anyone who has started to use products to treat their tooth sensitivity within the past three months. * Participant who is able to independently complete all activities online. * Participants residing in the United States. Exclusion Criteria: * Anyone who has any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period. * Participant whose sensitivity could be caused by other factors or clinical pathology than DH, as self-reported on the screening questionnaire, which include: 1. Anyone who suffers from tooth cavities, significant gum disease, cracked or fractured teeth, temporomandibular joint disease (TMD), or who has had tooth extractions or fillings within the last three months. 2. Anyone who wears braces (including Invisalign-like appliances) for treatment or dentures (full or partial). 3. Participant who has undergone treatment for periodontal or gum disease within 6 months of screening or is currently undergoing treatment for periodontal or gum disease. 4. Participant who has been informed by a Dental Health Care Professional (DHCP) that they have active periodontitis. 5. Participant who has been informed by a DHCP that they have active caries. 6. Participant with any chronic and/or severe painful health condition(s) which lead to regular use of pain relief medications (more than 3 days a week). * Anyone who has participated in another dentin hypersensitivity study within the last three months. * Currently participating in another research study or will be participating in any other research study at any point during this study's duration.

Primary outcome measure(s)

  • Change From Baseline in Total DHEQ Score Over 12 Months — Baseline and up to 12 Months
    Change from baseline in total DHEQ score and each of the domain scores (daily restrictions, coping behaviors, personal identity, social impact, emotional impact) over 12 months. The DHEQ has total 15 questions each will be scored on a scale ranging from 1 (strongly disagree) to 7 (strongly agree), thus total possible score will be ranging from 15 to 105, where higher score indicates worst outcome.

Trial sites (1)

FacilityCityRegionStatus
Citruslabs (Virtual Site) Las Vegas Nevada Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07337109 on ClinicalTrials.gov ↗ ← All trials in the USA